SlideShare a Scribd company logo
1 of 1
Download to read offline
Ø The strongest two sources we used are the pooled analysis and the
prospective cohort studies. The weakest source is case control.
Ø All the articles demonstrated a positive correlation between
nulliparity and risk of ovarian cancer.
Ø Some of the limitations of most of the studies are that they did not
control for potential confounding variables such as socioeconomic
status and age.
Ø  A few articles had potential risks for selection biases such as
Berkson's bias and recall bias. Some women were admitted to the
hospital for other medical conditions, which can increase the risk
for ovarian cancer.
Ø A possible reason for the positive association between nulliparity
and ovarian cancer has been attributed to the changes that a woman
undergoes during pregnancy. During this time, her ovaries do not
release additional eggs, and there are changes in the levels of
different hormones in her body. These changes are thought to help
protect women against ovarian cancer.
Ø Additionally, according to the pooled analysis article, another
reason for this positive association is the “incessant ovulation”
hypothesis, which postulates that every ovulation provokes micro-
traumas to the ovaries and exposure to follicular fluid. This is
suggested to increase the risk of ovarian cancer.
	
  
Nulliparity	
  and	
  Ovarian	
  Cancer	
  
	
  Nour	
  Matar	
  	
  -­‐	
  Zaynab	
  Albahrani	
  –	
  Jady	
  Lubin	
  –	
  Sophia	
  El	
  moumni	
  	
  
Epidemiology,	
  Faculty	
  of	
  Health	
  Sciences	
  of	
  the	
  University	
  of	
  OUawa	
  	
  
	
  	
  
Discussion
Results
Introduction
Methods
Abstract
References
	
  
	
  
Pooled	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
analysis	
  
	
  
Reproductive
factors and risk
of ovarian cancer
Factors and Risk of
Epithelial Ovarian
Cancer
Risk factors for ovarian
cancer
Hormonal risk factors for
ovarian cancer
Infertility, fertility drugs, and
invasive ovarian cancer
Risk Factors for Invasive Epithelial
Ovarian Cancer
Reproductive and hormonal factors and
ovarian cancer
Figure 1: Hierarchy of research design of the articles used from strongest to
weakest
Figure 2. Reprinted by: Riman, T., Dickman, P., Nilsson, S., Correia, N., & al, e. (2001). Risk Factors for
Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study, 367.
Figure 3. Reprinted by: Mosgaard, B., Lidegaard, O., Kjaer, S.K., & al, e. (1997). Infertility,
fertility drugs, and invasive ovarian cancer: a case-control study, 1008.
	
  	
  
Ø Ovarian cancer is an abnormal growth of cells in one or both of the
ovaries that can spread to different parts of the body. Epithelial ovarian
cancer is the most common, in which the spread of the cancer begins from
the epithelial tissue covering the ovaries.
Ø  The main symptoms of epithelial ovarian cancer are abdominal pain,
eating disorders and urinary problems (Webmed, 2013).
Ø According to the American Cancer Society, approximately 21 290 women
are newly diagnosed with ovarian cancer in America and about 14 180
women die because of it each year (American Cancer society, 2015).
“Is there an association between nulliparity and the risk of developing
ovarian cancer for women in North America and Europe?”
Ø This study aimed to assess a relationship between ovarian cancer and and
nulliparity ( i.e. does nulliparity increase the risk of developing ovarian
cancer), through a structured literature review.
Search Strategy
“Nulliparity AND risk of
ovarian cancer”
Included Search Words:
“United States of
America”, “Canada”,
“Europe”.
Excluded any non-English
articles
Database used:
Medline Ovid (n=233)
	
  
After Reading Abstracts,
Excluded:
(n=1) Obesity
(n=2) Specific Ethnicity
(n=2) Infertility
(n=4) Different cancers
Studies Used (n=8)
Prospective Cohort Studies (n=2)
Case-Control Studies (n=5)
Pooled Analysis (n=1)
	
  
Potential Articles for
Structured Literature
Review (n=17)
	
  
Conclusion	
  	
  
Ø There was a positive correlation between nulliparity and
ovarian cancer.
Ø For future directions, more research should be done to
reduce the amount of regular ovulations for women who
decide not to have children in order to decrease the micro-
traumas to the ovaries. However, it is important that this
treatment does not result in any negative impacts on a
woman’s health.
Ø Furthermore, as stated in one of the aforementioned
articles, further studies are needed to examine whether the
various histological types of tumors have different
etiologies (Hankinson, 1995).
	
  
Association between nulliparity and the risk of ovarian cancer : A Structured
Literature Review
Nour Matar1, Zaynab Albahrani2, Jady Lubin3, Sophia El moumni4
1Fourth year Health Sciences student at the University of Ottawa. 2 Fourth year
Health Sciences student at the University of Ottawa. 3 Fourth year Health Sciences
student at the University of Ottawa. 4 Fourth year Health Sciences student at the
University of Ottawa.
Background: Ovarian cancer is the fifth most common type of cancer, especially
in white women. About 50% of the diagnosis are among age 63 years and older
(American Cancer Society, 2015). Previous studies have shown an association
between reproductive factors such as nulliparity and postmenopausal ovarian
cancer (Hankinson, 2012).
Objective: To determine if an association exists between nulliparity and the
development of ovarian cancer for women in North America and Europe.
Method: Conducting a structured literature review through databases such as
Medline (Ovid).
Results: Obtained 17 different studies, chose 8 of which 2 were prospective
cohort, 5 were Case-Control, 1 was a pooled analysis (meta-analysis). Obtained
RRs , ORs, and CIs depending on the study.
Conclusion: A positive correlation between nulliparity and the development of
ovarian cancer was found.
	
  	
  
Figure 4. Reprinted by: Chiaffarino, F., Pelucchi, C., Parazzini, F., & al, e. (2001). Reproductive and
hormonal factors and ovarian cancer, 339
Meta-­‐Analysis	
  
Prospec/ve	
  Cohort	
  
Case-­‐Controls	
  
Name of Study Type of
study
Sample population Quantitative Measurements Results
1. Hormonal risk factors
for ovarian cancer in the
Albanian case-control
study
Case-
control
study
Cases
N = 283
Age: 24-74
Controls
N = 1019
-Frequency and distribution
analysis
-Chi square test of Pearson
-P-values (significant if <0.05)
-Odds Ratios OR (12.5)
-95% CI
-  Strong association between
nulliparous women and ovarian
cancer risk.
-  Decreased risk with increasing
number of childbirths.
2. Pooled analysis of 3
European case-control
studies: I. Reproductive
factors and risk of
epithelial ovarian cancer.
Meta-
analysis of
3 cases-
controls
studies
(Italy, UK
and Greece)
1st Study (Italy)
Cases
N = 755
Age: <75
Women with ovarian cancer
Controls
N = 2033
2nd Study (UK)
Cases
N = 235
Age: <65
Women with ovarian cancer
Controls
N = 451
3rd Study (Greece)
Cases
N = 150
Women with malignant ovarian
cancer
Controls
N = 250
-Relative Risk
0 children RR (1)
1 child RR (0.7)
3 children RR (0.5)
4 children RR (0.3)
-95 % CI
- Nulliparity and delay of first birth
until the age of 35 increases the risk.
- Having more children is a
protective factor for ovarian cancer.
3. Ovarian epithelial
tumors and reproductive
factors
Case-
control
study
Cases
N = 1031
Age: median of 56
Women with histologically confirmed ovarian
cancer
Controls
N = 2411
Age: median of 57
Women with the same geographical areas and
admitted to the same hospitals as cases, with acute
conditions unrelated to risk factors for ovarian cancer.
-Odds ratio
3 births OR (0.6)
> 4 births: OR (0.4)
-95% CI
Multiparity was associated with a
significant reduction in risk of
ovarian cancer.
4. Infertility, fertility
drugs, and invasive
ovarian cancer: a case-
control study
Case-
control
study
Cases
N = 684
Age: 18-59
Exclusion criteria:
Non-Danish inhabitants, those who had
malignancies other than ovarian cancer.
Controls
N = 1721
Women matched for area of residence and day/month
of birth.
Exclusion criteria: women who had undergone
bilateral oophorectomy
-Odds ratios
1 birth OR (0.47 to 1.02)
≥ 2 birth OR (0.33 to 0.69)
-95% CI
-Nulliparous women had an
increased risk of ovarian cancer
compared with parous women
-Nulliparity implies a 1.5 to 2 fold
increased risk of ovarian cancer.
5. Risk factors for
invasive Epithelial
Ovarian Cancer: Results
from a Swedish Case-
Control Study
Case-
control
study
Cases
N = 655 cases
Age: 50-74
Exclusion criteria: Women without any
previous ovarian malignancies or bilateral
oophorectomy.
Controls
N = 4148
Randomly selected women from a continuously
updated population register
Exclusion criteria: women who reported previous
bilateral oophorectomy.
-Parity reduced epithelial
ovarian cancer risk
-Odds ratio OR (0.61) for
uniparous compared with
nulliparous women.
-95% CI
-Parity reduced risk for uniparous
compared with nulliparous women
6. Reproductive factors
and risk of ovarian
cancer: a prospective
study
Prospective
cohort study
N = 63,090
Age: 27-69
Exclusion criteria: surgical removal of one or both ovaries, or other operations on the ovaries or
hysterectomy.
-Odds ratios >5 births OR (0.4)
-95% CI
-The risk of ovarian cancer declined
with increasing parity.
7. A Prospective Study of
Reproductive Factors and
Risk of Epithelial Ovarian
Cancer
Prospective
cohort study
N = 121,700
Age: 30-55
Female registered nurses
Exclusion criteria: participants who were diagnosed with cancer or who removed one or both ovaries.
-Relative Risk (RR) between
parity and ovarian cancer = 0.84
-95% CI
-A statistically significant inverse
association was observed between
parity and ovarian cancer risk.
8. Risk Factors for
Ovarian Cancer: a case
control-study
Case
Control
Study
Cases
N = 235
Diagnosed with epithelial ovarian cancer
Controls
N = 451
-Relative risk (RR) between
parity and ovarian cancer = 1.7
-95 % CI
-Nulliparous women had
a higher risk of ovarian cancer than
parous women
American	
  Cancer	
  society.	
  (March	
  12th	
  2015)	
  What	
  are	
  the	
  key	
  sta/s/cs	
  about	
  ovarian	
  cancer?	
  
hUp://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-­‐cancer-­‐key-­‐sta/s/cs.	
  March	
  23th	
  2015	
  
	
  
Booth,	
  M.,	
  Beral,	
  V.,	
  &	
  Smith,	
  P.	
  (1989).	
  Risk	
  factors	
  for	
  ovarian	
  cancer:	
  A	
  case-­‐control	
  study.	
  Bri%sh	
  Journal	
  of	
  Cancer,	
  60(4),	
  592-­‐598.	
  	
  
	
  
Chiaffarino,	
  F.,	
  Pelucchi,	
  C.,	
  Parazzini,	
  F.,	
  Negri,	
  E.,	
  Franceschi,	
  S.,	
  Talamini,	
  R.,	
  	
  La	
  Vecchia,	
  C.	
  (2001).	
  Reproduc/ve	
  and	
  hormonal	
  factors	
  and	
  ovarian	
  cancer.	
  Annals	
  
of	
  Oncology;	
  Ann.Oncol.,	
  12(3),	
  337-­‐341.	
  	
  
	
  
Hankinson,	
  S.	
  E.,	
  Colditz,	
  G.	
  A.,	
  Hunter,	
  D.	
  J.,	
  WilleU,	
  W.	
  C.,	
  Stampfer,	
  M.	
  J.,	
  Rosner,	
  B.,	
  .	
  .	
  Speizer,	
  F.	
  E.	
  (1995).	
  A	
  prospec/ve	
  study	
  of	
  reproduc/ve	
  factors	
  and	
  risk	
  
of	
  epithelial	
  ovarian	
  cancer.	
  Cancer,	
  76(2),	
  284-­‐290.	
  doi:10.1002/1097-­‐0142(19950715)76:2<284::AID-­‐CNCR2820760219>3.0.CO;2-­‐5	
  	
  
	
  
Kvale,	
  G.,	
  Heuch,	
  I.,	
  Nilssen,	
  S.,	
  &	
  Beral,	
  V.	
  (1988).	
  Reproduc/ve	
  factors	
  and	
  risk	
  of	
  ovarian	
  cancer:	
  A	
  prospec/ve	
  study.	
  Interna%onal	
  Journal	
  of	
  Cancer,	
  42(2),	
  
246-­‐251.	
  	
  
	
  
Mosgaard,	
  B.	
  J.,	
  Schou,	
  G.,	
  Lidegaard,	
  Ø.,	
  Andersen,	
  A.	
  N.,	
  &	
  Kjaer,	
  S.	
  K.	
  (1997).	
  Infer/lity,	
  fer/lity	
  drugs,	
  and	
  invasive	
  ovarian	
  cancer:	
  A	
  case-­‐	
  control	
  study.	
  Fer%lity	
  
and	
  Sterility,	
  67(6),	
  1005-­‐1012.	
  doi:10.1016/S0015-­‐0282(97)81431-­‐8	
  	
  
	
  
	
  
Negri,	
  E.,	
  Franceschi,	
  S.,	
  Tzonou,	
  A.,	
  Booth,	
  M.,	
  Lavecchia,	
  C.,	
  Parazzini,	
  F.,	
  .	
  Trichopoulos,	
  D.	
  (1991).	
  Pooled	
  analysis	
  of	
  3	
  european	
  case-­‐	
  control	
  studies	
  .1.	
  
reproduc/ve	
  factors	
  and	
  risk	
  of	
  epithelial	
  ovarian-­‐	
  cancer.	
  Interna%onal	
  Journal	
  of	
  Cancer;	
  Int.J.Cancer,	
  49(1),	
  50-­‐56.	
  	
  
	
  
Pajenga,	
  E.,	
  Rexha,	
  T.,	
  Celiku,	
  S.,	
  Bejtja,	
  G.,	
  &	
  Pisha,	
  M.	
  (2013).	
  Hormonal	
  risk	
  factors	
  for	
  ovarian	
  cancer	
  in	
  the	
  albanian	
  case-­‐	
  control	
  study.	
  Bosnian	
  Journal	
  of	
  Basic	
  
Medical	
  Sciences;	
  Bosnian	
  J.Basic	
  Med.Sci.,	
  13(2),	
  89-­‐93.	
  	
  
	
  
Riman,	
  T.,	
  Nilsson,	
  S.,	
  Dickman,	
  P.	
  W.,	
  Correia,	
  N.,	
  Magnusson,	
  C.	
  M.,	
  Persson,	
  I.	
  R.,	
  &	
  Nordlinder,	
  H.	
  (2002).	
  Risk	
  factors	
  for	
  invasive	
  epithelial	
  ovarian	
  cancer:	
  
Results	
  from	
  a	
  swedish	
  case-­‐	
  control	
  study.	
  American	
  Journal	
  of	
  Epidemiology,	
  156(4),	
  363-­‐373.	
  doi:10.1093/aje/kwf048	
  	
  
	
  
Webmed.	
  (June	
  28	
  2013)	
  What	
  is	
  ovarian	
  cancer	
  :topic	
  overview	
  hUp://www.webmd.com/ovarian-­‐cancer/guide/ovarian-­‐cancer-­‐topic-­‐overview.	
  April	
  1st	
  2015.	
  
	
  
	
  

More Related Content

What's hot

Navigating Nutrition During Cancer and COVID-19
Navigating Nutrition During Cancer and COVID-19Navigating Nutrition During Cancer and COVID-19
Navigating Nutrition During Cancer and COVID-19bkling
 
Am. j. epidemiol. 2016-robinson-388-99
Am. j. epidemiol. 2016-robinson-388-99Am. j. epidemiol. 2016-robinson-388-99
Am. j. epidemiol. 2016-robinson-388-99Esposito Evelyn
 
Preventing the preventable cancer
Preventing the preventable cancerPreventing the preventable cancer
Preventing the preventable cancerPathKind Labs
 
Bc and Hormones Presentation_Jan 2019_ References
Bc and Hormones Presentation_Jan 2019_ ReferencesBc and Hormones Presentation_Jan 2019_ References
Bc and Hormones Presentation_Jan 2019_ ReferencesKristinRojas1
 
YCN Breast Educational Meeting 2015 -Network breast data-Geoff Hall
YCN Breast Educational Meeting 2015 -Network breast data-Geoff HallYCN Breast Educational Meeting 2015 -Network breast data-Geoff Hall
YCN Breast Educational Meeting 2015 -Network breast data-Geoff HallJay Naik
 
Aggressive Breast Cancers in Black Women
Aggressive Breast Cancers in Black WomenAggressive Breast Cancers in Black Women
Aggressive Breast Cancers in Black Womenbkling
 
Overview of Cervical Cancer and HPV
Overview of Cervical Cancer and HPVOverview of Cervical Cancer and HPV
Overview of Cervical Cancer and HPVemphemory
 
Molecular diagnosis in breast cancer
Molecular diagnosis in breast cancerMolecular diagnosis in breast cancer
Molecular diagnosis in breast cancerAnkit Lalchandani
 
All in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic CancerAll in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic Cancerbkling
 
New Treatment Options for Uterine Cancer
New Treatment Options for Uterine CancerNew Treatment Options for Uterine Cancer
New Treatment Options for Uterine Cancerbkling
 
Hrt meme exeltis dernek 2017 son (1)
Hrt   meme  exeltis   dernek 2017 son (1)Hrt   meme  exeltis   dernek 2017 son (1)
Hrt meme exeltis dernek 2017 son (1)TrkiyeMenopozVeOsteo
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapyWalt Whitman
 

What's hot (20)

Navigating Nutrition During Cancer and COVID-19
Navigating Nutrition During Cancer and COVID-19Navigating Nutrition During Cancer and COVID-19
Navigating Nutrition During Cancer and COVID-19
 
Pediatric and young_adult_patients_and_oncofertility
Pediatric and young_adult_patients_and_oncofertilityPediatric and young_adult_patients_and_oncofertility
Pediatric and young_adult_patients_and_oncofertility
 
Am. j. epidemiol. 2016-robinson-388-99
Am. j. epidemiol. 2016-robinson-388-99Am. j. epidemiol. 2016-robinson-388-99
Am. j. epidemiol. 2016-robinson-388-99
 
Preventing the preventable cancer
Preventing the preventable cancerPreventing the preventable cancer
Preventing the preventable cancer
 
22case
22case22case
22case
 
Bc and Hormones Presentation_Jan 2019_ References
Bc and Hormones Presentation_Jan 2019_ ReferencesBc and Hormones Presentation_Jan 2019_ References
Bc and Hormones Presentation_Jan 2019_ References
 
Breast cancer myth and facts
Breast cancer myth and factsBreast cancer myth and facts
Breast cancer myth and facts
 
YCN Breast Educational Meeting 2015 -Network breast data-Geoff Hall
YCN Breast Educational Meeting 2015 -Network breast data-Geoff HallYCN Breast Educational Meeting 2015 -Network breast data-Geoff Hall
YCN Breast Educational Meeting 2015 -Network breast data-Geoff Hall
 
Aggressive Breast Cancers in Black Women
Aggressive Breast Cancers in Black WomenAggressive Breast Cancers in Black Women
Aggressive Breast Cancers in Black Women
 
Overview of Cervical Cancer and HPV
Overview of Cervical Cancer and HPVOverview of Cervical Cancer and HPV
Overview of Cervical Cancer and HPV
 
Molecular diagnosis in breast cancer
Molecular diagnosis in breast cancerMolecular diagnosis in breast cancer
Molecular diagnosis in breast cancer
 
All in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic CancerAll in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic Cancer
 
New Treatment Options for Uterine Cancer
New Treatment Options for Uterine CancerNew Treatment Options for Uterine Cancer
New Treatment Options for Uterine Cancer
 
Preservación de la fertilidad clínica mayo
Preservación de la fertilidad clínica mayoPreservación de la fertilidad clínica mayo
Preservación de la fertilidad clínica mayo
 
Hrt meme exeltis dernek 2017 son (1)
Hrt   meme  exeltis   dernek 2017 son (1)Hrt   meme  exeltis   dernek 2017 son (1)
Hrt meme exeltis dernek 2017 son (1)
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapy
 
Breast cancer 2021
Breast cancer 2021Breast cancer 2021
Breast cancer 2021
 
Myth About Cancer By Rcdohare
Myth About Cancer By RcdohareMyth About Cancer By Rcdohare
Myth About Cancer By Rcdohare
 
Breast cancer handout
Breast cancer handoutBreast cancer handout
Breast cancer handout
 
Women cancer
Women cancerWomen cancer
Women cancer
 

Similar to OVARIAN CANCER & NULLIPARITY

Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Basalama Ali
 
JOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxJOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxAkshata Darandale
 
Risk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfRisk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfYelmi Reni Putri SY
 
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxSUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxpicklesvalery
 
SAMPLE SIZE PG 2-2.pdf
SAMPLE SIZE PG 2-2.pdfSAMPLE SIZE PG 2-2.pdf
SAMPLE SIZE PG 2-2.pdfssuser82d3bb
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxduketjoy27252
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxlynettearnold46882
 
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxAssignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxrock73
 
Breast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistanceBreast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistanceSpringer
 
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...DrHeena tiwari
 
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:Mario Guillermo Simonovich
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...UCLA
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddahBasalama Ali
 
Study the role of estradiol and luteinizing hormones in breast tumors inciden...
Study the role of estradiol and luteinizing hormones in breast tumors inciden...Study the role of estradiol and luteinizing hormones in breast tumors inciden...
Study the role of estradiol and luteinizing hormones in breast tumors inciden...Alexander Decker
 

Similar to OVARIAN CANCER & NULLIPARITY (20)

Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1
 
JOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxJOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptx
 
Uzma
UzmaUzma
Uzma
 
Risk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfRisk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdf
 
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxSUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
 
SAMPLE SIZE PG 2-2.pdf
SAMPLE SIZE PG 2-2.pdfSAMPLE SIZE PG 2-2.pdf
SAMPLE SIZE PG 2-2.pdf
 
Research Day Poster
Research Day PosterResearch Day Poster
Research Day Poster
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docx
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docx
 
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxAssignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
 
Breast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistanceBreast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistance
 
Breast Poster
Breast PosterBreast Poster
Breast Poster
 
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
 
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:
BREAST CANCER AND SOME EPIDEMIOLOGICAL FACTORS:
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
 
Ovarian Malignancy ppt
Ovarian Malignancy  pptOvarian Malignancy  ppt
Ovarian Malignancy ppt
 
Cancer 2018
Cancer 2018Cancer 2018
Cancer 2018
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddah
 
Study the role of estradiol and luteinizing hormones in breast tumors inciden...
Study the role of estradiol and luteinizing hormones in breast tumors inciden...Study the role of estradiol and luteinizing hormones in breast tumors inciden...
Study the role of estradiol and luteinizing hormones in breast tumors inciden...
 

OVARIAN CANCER & NULLIPARITY

  • 1. Ø The strongest two sources we used are the pooled analysis and the prospective cohort studies. The weakest source is case control. Ø All the articles demonstrated a positive correlation between nulliparity and risk of ovarian cancer. Ø Some of the limitations of most of the studies are that they did not control for potential confounding variables such as socioeconomic status and age. Ø  A few articles had potential risks for selection biases such as Berkson's bias and recall bias. Some women were admitted to the hospital for other medical conditions, which can increase the risk for ovarian cancer. Ø A possible reason for the positive association between nulliparity and ovarian cancer has been attributed to the changes that a woman undergoes during pregnancy. During this time, her ovaries do not release additional eggs, and there are changes in the levels of different hormones in her body. These changes are thought to help protect women against ovarian cancer. Ø Additionally, according to the pooled analysis article, another reason for this positive association is the “incessant ovulation” hypothesis, which postulates that every ovulation provokes micro- traumas to the ovaries and exposure to follicular fluid. This is suggested to increase the risk of ovarian cancer.   Nulliparity  and  Ovarian  Cancer    Nour  Matar    -­‐  Zaynab  Albahrani  –  Jady  Lubin  –  Sophia  El  moumni     Epidemiology,  Faculty  of  Health  Sciences  of  the  University  of  OUawa         Discussion Results Introduction Methods Abstract References     Pooled                                                                                                       analysis     Reproductive factors and risk of ovarian cancer Factors and Risk of Epithelial Ovarian Cancer Risk factors for ovarian cancer Hormonal risk factors for ovarian cancer Infertility, fertility drugs, and invasive ovarian cancer Risk Factors for Invasive Epithelial Ovarian Cancer Reproductive and hormonal factors and ovarian cancer Figure 1: Hierarchy of research design of the articles used from strongest to weakest Figure 2. Reprinted by: Riman, T., Dickman, P., Nilsson, S., Correia, N., & al, e. (2001). Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study, 367. Figure 3. Reprinted by: Mosgaard, B., Lidegaard, O., Kjaer, S.K., & al, e. (1997). Infertility, fertility drugs, and invasive ovarian cancer: a case-control study, 1008.     Ø Ovarian cancer is an abnormal growth of cells in one or both of the ovaries that can spread to different parts of the body. Epithelial ovarian cancer is the most common, in which the spread of the cancer begins from the epithelial tissue covering the ovaries. Ø  The main symptoms of epithelial ovarian cancer are abdominal pain, eating disorders and urinary problems (Webmed, 2013). Ø According to the American Cancer Society, approximately 21 290 women are newly diagnosed with ovarian cancer in America and about 14 180 women die because of it each year (American Cancer society, 2015). “Is there an association between nulliparity and the risk of developing ovarian cancer for women in North America and Europe?” Ø This study aimed to assess a relationship between ovarian cancer and and nulliparity ( i.e. does nulliparity increase the risk of developing ovarian cancer), through a structured literature review. Search Strategy “Nulliparity AND risk of ovarian cancer” Included Search Words: “United States of America”, “Canada”, “Europe”. Excluded any non-English articles Database used: Medline Ovid (n=233)   After Reading Abstracts, Excluded: (n=1) Obesity (n=2) Specific Ethnicity (n=2) Infertility (n=4) Different cancers Studies Used (n=8) Prospective Cohort Studies (n=2) Case-Control Studies (n=5) Pooled Analysis (n=1)   Potential Articles for Structured Literature Review (n=17)   Conclusion     Ø There was a positive correlation between nulliparity and ovarian cancer. Ø For future directions, more research should be done to reduce the amount of regular ovulations for women who decide not to have children in order to decrease the micro- traumas to the ovaries. However, it is important that this treatment does not result in any negative impacts on a woman’s health. Ø Furthermore, as stated in one of the aforementioned articles, further studies are needed to examine whether the various histological types of tumors have different etiologies (Hankinson, 1995).   Association between nulliparity and the risk of ovarian cancer : A Structured Literature Review Nour Matar1, Zaynab Albahrani2, Jady Lubin3, Sophia El moumni4 1Fourth year Health Sciences student at the University of Ottawa. 2 Fourth year Health Sciences student at the University of Ottawa. 3 Fourth year Health Sciences student at the University of Ottawa. 4 Fourth year Health Sciences student at the University of Ottawa. Background: Ovarian cancer is the fifth most common type of cancer, especially in white women. About 50% of the diagnosis are among age 63 years and older (American Cancer Society, 2015). Previous studies have shown an association between reproductive factors such as nulliparity and postmenopausal ovarian cancer (Hankinson, 2012). Objective: To determine if an association exists between nulliparity and the development of ovarian cancer for women in North America and Europe. Method: Conducting a structured literature review through databases such as Medline (Ovid). Results: Obtained 17 different studies, chose 8 of which 2 were prospective cohort, 5 were Case-Control, 1 was a pooled analysis (meta-analysis). Obtained RRs , ORs, and CIs depending on the study. Conclusion: A positive correlation between nulliparity and the development of ovarian cancer was found.     Figure 4. Reprinted by: Chiaffarino, F., Pelucchi, C., Parazzini, F., & al, e. (2001). Reproductive and hormonal factors and ovarian cancer, 339 Meta-­‐Analysis   Prospec/ve  Cohort   Case-­‐Controls   Name of Study Type of study Sample population Quantitative Measurements Results 1. Hormonal risk factors for ovarian cancer in the Albanian case-control study Case- control study Cases N = 283 Age: 24-74 Controls N = 1019 -Frequency and distribution analysis -Chi square test of Pearson -P-values (significant if <0.05) -Odds Ratios OR (12.5) -95% CI -  Strong association between nulliparous women and ovarian cancer risk. -  Decreased risk with increasing number of childbirths. 2. Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer. Meta- analysis of 3 cases- controls studies (Italy, UK and Greece) 1st Study (Italy) Cases N = 755 Age: <75 Women with ovarian cancer Controls N = 2033 2nd Study (UK) Cases N = 235 Age: <65 Women with ovarian cancer Controls N = 451 3rd Study (Greece) Cases N = 150 Women with malignant ovarian cancer Controls N = 250 -Relative Risk 0 children RR (1) 1 child RR (0.7) 3 children RR (0.5) 4 children RR (0.3) -95 % CI - Nulliparity and delay of first birth until the age of 35 increases the risk. - Having more children is a protective factor for ovarian cancer. 3. Ovarian epithelial tumors and reproductive factors Case- control study Cases N = 1031 Age: median of 56 Women with histologically confirmed ovarian cancer Controls N = 2411 Age: median of 57 Women with the same geographical areas and admitted to the same hospitals as cases, with acute conditions unrelated to risk factors for ovarian cancer. -Odds ratio 3 births OR (0.6) > 4 births: OR (0.4) -95% CI Multiparity was associated with a significant reduction in risk of ovarian cancer. 4. Infertility, fertility drugs, and invasive ovarian cancer: a case- control study Case- control study Cases N = 684 Age: 18-59 Exclusion criteria: Non-Danish inhabitants, those who had malignancies other than ovarian cancer. Controls N = 1721 Women matched for area of residence and day/month of birth. Exclusion criteria: women who had undergone bilateral oophorectomy -Odds ratios 1 birth OR (0.47 to 1.02) ≥ 2 birth OR (0.33 to 0.69) -95% CI -Nulliparous women had an increased risk of ovarian cancer compared with parous women -Nulliparity implies a 1.5 to 2 fold increased risk of ovarian cancer. 5. Risk factors for invasive Epithelial Ovarian Cancer: Results from a Swedish Case- Control Study Case- control study Cases N = 655 cases Age: 50-74 Exclusion criteria: Women without any previous ovarian malignancies or bilateral oophorectomy. Controls N = 4148 Randomly selected women from a continuously updated population register Exclusion criteria: women who reported previous bilateral oophorectomy. -Parity reduced epithelial ovarian cancer risk -Odds ratio OR (0.61) for uniparous compared with nulliparous women. -95% CI -Parity reduced risk for uniparous compared with nulliparous women 6. Reproductive factors and risk of ovarian cancer: a prospective study Prospective cohort study N = 63,090 Age: 27-69 Exclusion criteria: surgical removal of one or both ovaries, or other operations on the ovaries or hysterectomy. -Odds ratios >5 births OR (0.4) -95% CI -The risk of ovarian cancer declined with increasing parity. 7. A Prospective Study of Reproductive Factors and Risk of Epithelial Ovarian Cancer Prospective cohort study N = 121,700 Age: 30-55 Female registered nurses Exclusion criteria: participants who were diagnosed with cancer or who removed one or both ovaries. -Relative Risk (RR) between parity and ovarian cancer = 0.84 -95% CI -A statistically significant inverse association was observed between parity and ovarian cancer risk. 8. Risk Factors for Ovarian Cancer: a case control-study Case Control Study Cases N = 235 Diagnosed with epithelial ovarian cancer Controls N = 451 -Relative risk (RR) between parity and ovarian cancer = 1.7 -95 % CI -Nulliparous women had a higher risk of ovarian cancer than parous women American  Cancer  society.  (March  12th  2015)  What  are  the  key  sta/s/cs  about  ovarian  cancer?   hUp://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-­‐cancer-­‐key-­‐sta/s/cs.  March  23th  2015     Booth,  M.,  Beral,  V.,  &  Smith,  P.  (1989).  Risk  factors  for  ovarian  cancer:  A  case-­‐control  study.  Bri%sh  Journal  of  Cancer,  60(4),  592-­‐598.       Chiaffarino,  F.,  Pelucchi,  C.,  Parazzini,  F.,  Negri,  E.,  Franceschi,  S.,  Talamini,  R.,    La  Vecchia,  C.  (2001).  Reproduc/ve  and  hormonal  factors  and  ovarian  cancer.  Annals   of  Oncology;  Ann.Oncol.,  12(3),  337-­‐341.       Hankinson,  S.  E.,  Colditz,  G.  A.,  Hunter,  D.  J.,  WilleU,  W.  C.,  Stampfer,  M.  J.,  Rosner,  B.,  .  .  Speizer,  F.  E.  (1995).  A  prospec/ve  study  of  reproduc/ve  factors  and  risk   of  epithelial  ovarian  cancer.  Cancer,  76(2),  284-­‐290.  doi:10.1002/1097-­‐0142(19950715)76:2<284::AID-­‐CNCR2820760219>3.0.CO;2-­‐5       Kvale,  G.,  Heuch,  I.,  Nilssen,  S.,  &  Beral,  V.  (1988).  Reproduc/ve  factors  and  risk  of  ovarian  cancer:  A  prospec/ve  study.  Interna%onal  Journal  of  Cancer,  42(2),   246-­‐251.       Mosgaard,  B.  J.,  Schou,  G.,  Lidegaard,  Ø.,  Andersen,  A.  N.,  &  Kjaer,  S.  K.  (1997).  Infer/lity,  fer/lity  drugs,  and  invasive  ovarian  cancer:  A  case-­‐  control  study.  Fer%lity   and  Sterility,  67(6),  1005-­‐1012.  doi:10.1016/S0015-­‐0282(97)81431-­‐8         Negri,  E.,  Franceschi,  S.,  Tzonou,  A.,  Booth,  M.,  Lavecchia,  C.,  Parazzini,  F.,  .  Trichopoulos,  D.  (1991).  Pooled  analysis  of  3  european  case-­‐  control  studies  .1.   reproduc/ve  factors  and  risk  of  epithelial  ovarian-­‐  cancer.  Interna%onal  Journal  of  Cancer;  Int.J.Cancer,  49(1),  50-­‐56.       Pajenga,  E.,  Rexha,  T.,  Celiku,  S.,  Bejtja,  G.,  &  Pisha,  M.  (2013).  Hormonal  risk  factors  for  ovarian  cancer  in  the  albanian  case-­‐  control  study.  Bosnian  Journal  of  Basic   Medical  Sciences;  Bosnian  J.Basic  Med.Sci.,  13(2),  89-­‐93.       Riman,  T.,  Nilsson,  S.,  Dickman,  P.  W.,  Correia,  N.,  Magnusson,  C.  M.,  Persson,  I.  R.,  &  Nordlinder,  H.  (2002).  Risk  factors  for  invasive  epithelial  ovarian  cancer:   Results  from  a  swedish  case-­‐  control  study.  American  Journal  of  Epidemiology,  156(4),  363-­‐373.  doi:10.1093/aje/kwf048       Webmed.  (June  28  2013)  What  is  ovarian  cancer  :topic  overview  hUp://www.webmd.com/ovarian-­‐cancer/guide/ovarian-­‐cancer-­‐topic-­‐overview.  April  1st  2015.